4 results
P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 409s
-
- Article
-
- You have access
- Export citation
P02.316 Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study)
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 407s
-
- Article
-
- You have access
- Export citation
P02.319 Antipsychotic treatment, adverse events and health-related quality of life
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 408s
-
- Article
-
- You have access
- Export citation
P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO)
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 408s
-
- Article
-
- You have access
- Export citation